Detalhe da pesquisa
1.
VEGFR2 activation mediates the pro-angiogenic activity of BMP4.
Angiogenesis
; 22(4): 521-533, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31363885
2.
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
J Pathol
; 230(2): 228-38, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23424081
3.
Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.
Arterioscler Thromb Vasc Biol
; 32(3): 696-703, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267482
4.
Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation.
J Am Chem Soc
; 134(35): 14573-9, 2012 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22860754
5.
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
Blood
; 116(18): 3677-80, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660291
6.
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-ß2).
Nutrients
; 14(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36079847
7.
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
J Cell Mol Med
; 14(8): 2109-21, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19627396
8.
A pro-inflammatory signature mediates FGF2-induced angiogenesis.
J Cell Mol Med
; 13(8B): 2083-2108, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18624773
9.
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.
Sensors (Basel)
; 9(8): 6471-503, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454596
10.
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Arterioscler Thromb Vasc Biol
; 25(1): 71-6, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15514208
11.
Focal adhesion molecules as potential target of lead toxicity in NRK-52E cell line.
FEBS Lett
; 579(27): 6251-8, 2005 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16253243
12.
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
Mol Cancer Ther
; 12(12): 2760-71, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130051
13.
Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.
Mol Cancer Ther
; 10(9): 1600-10, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21764903
14.
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions.
Biosens Bioelectron
; 26(4): 1571-5, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20810271
15.
Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.
Mol Cancer Ther
; 9(12): 3244-53, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940322
16.
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.
Eur Cytokine Netw
; 20(2): 39-50, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19541589
17.
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Eur Cytokine Netw
; 20(4): 225-34, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20167562
18.
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement.
J Biol Chem
; 282(27): 19676-84, 2007 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17456474
19.
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
J Immunol
; 177(7): 4267-70, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16982859
20.
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
J Immunol
; 171(2): 1085-93, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12847283